Can Fite Biopharma Ltd ADR (CANF)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $4.73M
Last updated: Nov 17, 2026 at 4:31 PM ET
Can Fite Biopharma Ltd ADR (CANF) Stock Chart
Can Fite Biopharma Ltd ADR (CANF) has a latest price of $1.50 on Nov 17, 2026, 80.9% below its 52-week high of $7.90. Its price fell 79.7% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 56.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $7,256.37 in Oct 2016 and its lowest $1.62 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CANF with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CANF.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 56.8%, and over 6 months it fell 53.7%. The month-end price fell 96.0% over the 3 years through Oct 2026, a compound annual decline of 65.8%.
| Period | Change |
|---|---|
| 1 month | -20.4% |
| 3 months | -56.8% |
| 6 months | -53.7% |
| 12 months | -79.7% |
| 12 months, with dividends | -79.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.0% | -65.8% |
| 5 years | -99.5% | -64.9% |
| 10 years | -100.0% | -56.9% |
Price by Year
Its best calendar year was 2018, when the price fell 14.9%, and its weakest was 2025, when it fell 87.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.62 | -59.5% |
| 2025 | $4.00 | -87.7% |
| 2024 | $32.50 | -26.1% |
| 2023 | $44.00 | -64.1% |
| 2022 | $122.60 | -52.5% |
| 2021 | $258.00 | -27.5% |
| 2020 | $356.00 | -46.1% |
| 2019 | $660.00 | -82.5% |
| 2018 | $3,778.11 | -14.9% |
| 2017 | $4,437.78 | -37.8% |
Trading Range
The price is 21.8% below its 50-day average of $1.92 and 50.7% below its 200-day average of $3.05.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.50 | |
| 52-week high | $7.90 | -80.9% |
| 52-week low | $1.42 | +6.0% |
| 50-day average | $1.92 | -21.8% |
| 200-day average | $3.05 | -50.7% |
Price Risk
Over 3 years, its largest fall from a peak was 98.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.66 |
| Largest fall, 1 year | -81.7% |
| Largest fall, 3 years | -98.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CANF
What is CANF's 1-year price change?
Can Fite Biopharma Ltd ADR's price fell 79.7% over the past 12 months. With dividends included, the 12-month total return was -79.7%.
What is CANF's 5-year price change?
Can Fite Biopharma Ltd ADR's month-end price fell 99.5% over the 5 years through Oct 2026, a compound annual decline of 64.9%. These figures leave out dividends.
What is CANF's 52-week high and low?
Can Fite Biopharma Ltd ADR's 52-week high is $7.90 and its 52-week low is $1.42. Its latest price of $1.50 on Nov 17, 2026 is 80.9% below the high.
What is CANF's beta?
Can Fite Biopharma Ltd ADR's 1-year beta against the S&P 500 is 0.66, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 81.7%.
Is the CANF chart free?
Yes. Advanced Charting for CANF is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CANF pages: Overview, Charting, Financials